| 181 |
Muscle and Nerve
|
John Wiley & Sons Inc. |
10974598, 0148639X |
Q1 |
1.134 |
| 182 |
Cognitive Research: Principles and Implications
|
SpringerOpen |
23657464 |
Q1 |
1.130 |
| 183 |
Molecular and Cellular Neuroscience
|
Academic Press Inc. |
10959327, 10447431 |
Q2 |
1.124 |
| 184 |
Neurogastroenterology and Motility
|
Wiley-Blackwell Publishing Ltd |
13652982, 13501925 |
Q3 |
1.117 |
| 185 |
Ophthalmic and Physiological Optics
|
Springer Nature |
02755408, 14751313 |
Q1 |
1.117 |
| 186 |
Visual Neuroscience
|
Maximum Academic Press |
14698714, 09525238 |
Q1 |
1.116 |
| 187 |
Expert Review of Neurotherapeutics
|
Taylor and Francis Ltd. |
14737175, 17448360 |
Q2 |
1.106 |
| 188 |
ACS Chemical Neuroscience
|
American Chemical Society |
19487193 |
Q2 |
1.100 |
| 189 |
Hippocampus
|
Wiley-Liss Inc. |
10981063, 10509631 |
Q3 |
1.098 |
| 190 |
Neurophotonics
|
SPIE |
2329423X, 23294248 |
Q2 |
1.096 |
| 191 |
Journal of Alzheimer's Disease
|
SAGE Publications Ltd |
13872877, 18758908 |
Q1 |
1.093 |
| 192 |
Current Research in Neurobiology
|
Elsevier B.V. |
2665945X |
Q3 |
1.090 |
| 193 |
Neuropsychobiology
|
S. Karger AG |
0302282X, 14230224 |
Q1 |
1.082 |
| 194 |
Frontiers in Integrative Neuroscience
|
Frontiers Media SA |
16625145 |
Q3 |
1.079 |
| 195 |
Autonomic Neuroscience: Basic and Clinical
|
Elsevier B.V. |
15660702, 18727484 |
Q1 |
1.077 |
| 196 |
Frontiers in Behavioral Neuroscience
|
Frontiers Media SA |
16625153 |
Q2 |
1.077 |
| 197 |
Neuroscience Informatics
|
Elsevier Masson s.r.l. |
27725286 |
Q1 |
1.077 |
| 198 |
Neuromodulation
|
International Neuromodulation Society |
15251403, 10947159 |
Q2 |
1.076 |
| 199 |
Graefe's Archive for Clinical and Experimental Ophthalmology
|
Springer Science and Business Media Deutschland GmbH |
0721832X, 1435702X |
Q1 |
1.073 |
| 200 |
Neuroethics
|
Springer Science and Business Media B.V. |
18745490, 18745504 |
Q1 |
1.073 |
| 201 |
Journal of Neuroscience Research
|
Wiley-Liss Inc. |
10974547, 03604012 |
Q3 |
1.071 |
| 202 |
Clinical Neurophysiology
|
Elsevier Ireland Ltd |
13882457, 18728952 |
Q2 |
1.070 |
| 203 |
Translational Behavioral Medicine
|
Oxford University Press |
16139860, 18696716 |
Q2 |
1.069 |
| 204 |
Frontiers in Neuroscience
|
Frontiers Media SA |
1662453X, 16624548 |
Q2 |
1.068 |
| 205 |
Clinical Autonomic Research
|
Springer Science and Business Media Deutschland GmbH |
09599851, 16191560 |
Q1 |
1.067 |
| 206 |
Journal of Neuromuscular Diseases
|
SAGE Publications Ltd |
22143599, 22143602 |
Q2 |
1.066 |
| 207 |
Molecular Pain
|
SAGE Publications Inc. |
17448069 |
Q2 |
1.058 |
| 208 |
Neurobiology of Pain
|
Elsevier B.V. |
2452073X |
Q2 |
1.058 |
| 209 |
Genes, Brain and Behavior
|
Wiley-Blackwell Publishing Ltd |
1601183X, 16011848 |
Q3 |
1.054 |
| 210 |
Frontiers in Neuroanatomy
|
Frontiers Media SA |
16625129 |
Q3 |
1.052 |
| 211 |
Early Intervention in Psychiatry
|
Wiley-Blackwell Publishing Ltd |
17517885, 17517893 |
Q3 |
1.045 |
| 212 |
Cerebellum
|
Springer |
14734230, 14734222 |
Q3 |
1.040 |
| 213 |
Journal of the Neurological Sciences
|
Elsevier B.V. |
0022510X, 18785883 |
Q3 |
1.040 |
| 214 |
Current Protocols
|
John Wiley and Sons Inc |
26911299 |
Q3 |
1.039 |
| 215 |
Journal of Clinical Sleep Medicine
|
Springer Nature |
15509397, 15509389 |
Q2 |
1.033 |
| 216 |
Journal of Neuro-Oncology
|
Springer |
15737373, 0167594X |
Q2 |
1.030 |
| 217 |
NeuroToxicology
|
Elsevier B.V. |
18729711, 0161813X |
Q2 |
1.026 |
| 218 |
Journal of Movement Disorders
|
Korean Movement Disorder Society |
2005940X, 20934939 |
Q1 |
1.026 |
| 219 |
Nature and Science of Sleep
|
Dove Medical Press Ltd |
11791608 |
Q2 |
1.025 |
| 220 |
eNeuro
|
Society for Neuroscience |
23732822 |
Q3 |
1.016 |
| 221 |
Journal of Neural Engineering
|
Institute of Physics |
17412552, 17412560 |
Q2 |
1.016 |
| 222 |
Peptides
|
Elsevier Inc. |
18735169, 01969781 |
Q2 |
1.009 |
| 223 |
American Journal of Alzheimer's Disease and other Dementias
|
SAGE Publications Inc. |
15333175, 19382731 |
Q1 |
1.002 |
| 224 |
Frontiers in Neurology
|
Frontiers Media SA |
16642295 |
Q2 |
0.995 |
| 225 |
Metabolic Brain Disease
|
Springer |
15737365, 08857490 |
Q2 |
0.995 |
| 226 |
CNS Oncology
|
Taylor and Francis Ltd. |
20450915, 20450907 |
Q2 |
0.992 |
| 227 |
Journal of Comparative Neurology
|
Wiley-Liss Inc. |
10969861, 00219967 |
Q1 |
0.992 |
| 228 |
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
|
Taylor and Francis Ltd. |
21679223, 21678421 |
Q3 |
0.990 |
| 229 |
Borderline Personality Disorder and Emotion Dysregulation
|
BioMed Central Ltd |
20516673 |
Q2 |
0.989 |
| 230 |
British Journal of Developmental Psychology
|
Wiley-Blackwell |
2044835X, 0261510X |
Q3 |
0.987 |
| 231 |
Developmental Neurobiology
|
John Wiley & Sons Inc. |
1932846X, 19328451 |
Q4 |
0.985 |
| 232 |
Behavioral and Brain Functions
|
BioMed Central Ltd |
17449081 |
Q3 |
0.983 |
| 233 |
International Journal of Psychophysiology
|
Elsevier B.V. |
18727697, 01678760 |
Q1 |
0.982 |
| 234 |
Aging Brain
|
Elsevier Inc. |
25899589 |
Q3 |
0.979 |
| 235 |
NeuroMolecular Medicine
|
Springer |
15351084, 15591174 |
Q2 |
0.979 |
| 236 |
Cognitive Science
|
Wiley-Blackwell |
03640213, 15516709 |
Q2 |
0.978 |
| 237 |
Clinical Psychopharmacology and Neuroscience
|
Korean College of Neuropsychopharmacology |
20934327, 17381088 |
Q2 |
0.976 |
| 238 |
Brain-X
|
John Wiley and Sons Inc |
28353153 |
Q1 |
0.972 |
| 239 |
Nutritional Neuroscience
|
Taylor and Francis Ltd. |
14768305, 1028415X |
Q2 |
0.970 |
| 240 |
Brain Imaging and Behavior
|
Springer |
19317565, 19317557 |
Q2 |
0.962 |